Levels of hepatitis B virus (HBV) replication during the nonreplicative phase: HBV quantification by real-time PCR in Korea

Digestive Diseases and Sciences

Volumn 52, Issue 9, 2007, Pages 2403-2409

  Yim, Hyung Joon ^a   Byun, Kwan Soo ^a,c   Chang, Yun Jung ^a   Suh, Yeon Seok ^a   Yeon, Jong Eun ^a   Lee, Chang Hong ^a   Kwon, Jung Ah ^a   Yoo, Wangdon ^b   Kim, Soo Ok ^b   Hong, Sun Pyo ^b  

^a Korea University College of Medicine   (South Korea)

^b GeneMatrix Inc   (South Korea)

^c Korea University College of Medicine   (South Korea)

Author keywords

HBsAg loss; Hepatitis B virus DNA; Inactive HBsAg carriers; Nonreplicative phase; Real time PCR

Indexed keywords

HEPATITIS B ANTIGEN; VIRUS DNA;

ADULT; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; KOREA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; VIRUS REPLICATION;

ADULT; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INCIDENCE; KOREA; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROGNOSIS; SEVERITY OF ILLNESS INDEX; VIRUS REPLICATION;

EID: 34547843613     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-9140-2     Document Type: Article

References (30)

1. Liaw YF, Sheen IS, Chen TJ, Chu CM, Pao CC (1991) Incidence, determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection: A prospective study. Hepatology 13:627-631
2. Papatheodoridis GV, Hadziyannis SJ (2001) Diagnosis and management of pre-core mutant chronic hepatitis B. J Viral Hepat 8:311-321
3. Lok ASF, McMahon BJ (2001) Chronic hepatitis B. Hepatology 34:1225-1241
4. Manesis EK, Papatheodoridis GV, Sevastianos V, Cholongitas E, Papaioannou C, Hadziyannis SJ (2003) Significance of hepatitis B viremia levels determined by a quantitative polymerase chain reaction assay in patients with hepatitis B e antigen-negative chronic hepatitis B virus infection. Am J Gastroenterol 98:2261-2267
5. Song BC, Cui XJ, Kim H (2005) Hepatitis B virus genotypes in Korea: An endemic area of hepatitis B virus infection. Intervirology 48:133-137
6. Lee SH, Han SH, Cho SC, Roh BJ, Sohn JH, Kim DA, Lee DH, Kee CS (2001) Distribution of HBV genotypes in patients with chronic HBV infection in Korea. Korean J Hepatol 7:373-380
7. Norder H, Courouce AM, Coursaget P, Echevarria JM, Lee SD, Mushahwar IK, Robertson BH, Locarnini S, Magnius LO (2004) Genetic diversity of hepatitis B virus strains derived worldwide: Genotypes, subgenotypes, and HBsAg subtypes. Intervirology 47:289-309
8. Yu MW, Yeh SH, Chen PJ, Liaw YF, Lin CL, Liu CJ, Shih WL, Kao JH, Chen DS, Chen CJ (2005) Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: A prospective study in men. J Natl Cancer Inst 97:265-272
9. Chung HT, Lai CL, Lok AS (1995) Pathogenic role of hepatitis B virus in hepatitis B surface antigen-negative decompensated cirrhosis. Hepatology 22:25-29
10. Niesters HG (2001) Quantitation of viral load using real-time amplification techniques. Methods 25:419-429
11. Nurmi J, Ylikoski A, Soukka T, Karp M, Lovgren T (2000) A new label technology for the detection of specific polymerase chain reaction products in a closed tube. Nucleic Acids Res 28:e28
12. Ono Y, Onda H, Sasada R, Igarashi K, Sugino Y, Nishioka K (1983) The complete nucleotide sequences of the cloned hepatitis B virus DNA; subtype adr and adw. Nucleic Acids Res 11:1747-1757
13. Saldanha J, Gerlich W, Lelie N, Dawson P, Heermann K, Heath A, WHO Collaborative Study Group (2001) An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniques. Vox Sang 80:63-71
14. Yao JD, Beld MG, Oon LL, Sherlock CH, Germer J, Menting S, Se Thoe SY, Merrick L, Ziermann R, Surtihadi J, Hnatyszyn HJ (2004) Multicenter evaluation of the VERSANT hepatitis B virus DNA 3.0 assay. J Clin Microbiol 42:800-806
15. Pawlotsky JM (2003) Hepatitis B virus (HBV) DNA assays (methods and practical use) and viral kinetics. J Hepatol 39(Suppl 1):31-35
16. Aliyu SH, Aliyu MH, Salihu HM, Parmar S, Jalal H, Curran MD (2004) Rapid detection and quantitation of hepatitis B virus DNA by real-time PCR using a new fluorescent (FRET) detection system. J Clin Virol 30:191-195
17. Martinot-Peignoux M, Boyer N, Colombat M, Akremi R, Pham BN, Ollivier S, Castelnau C, Valla D, Degott C, Marcellin P (2002) Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers. J Hepatol 36:543-546
18. Yuen MF, Wong DK, Sablon E, Tse E, Ng IO, Yuan HJ, Siu CW, Sander TJ, Bourne EJ, Hall JG, Condreay LD, Lai CL (2004) HBsAg seroclearance in chronic hepatitis B in the Chinese: Virological, histological, and clinical aspects. Hepatology 39:1694-1701
19. Chen YC, Sheen IS, Chu CM, Liaw YF (2002) Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection. Gastroenterology 123:1084-1089
20. Fattovich G (2003) Natural history of hepatitis B. J Hepatol 39(Suppl 1):50-58
21. Chu CM, Liaw YF (1997) Natural history of chronic hepatitis B virus infection: An immunopathological study. J Gastroenterol Hepatol 12(Suppl):S218-S222
22. Chu CM (2000) Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma. J Gastroenterol Hepatol 15(Suppl):E25-E30
23. de Franchis R, Meucci G, Vecchi M, Tatarella M, Colombo M, Del Ninno E, Rumi MG, Donato MF, Ronchi G (1993) The natural history of asymptomatic hepatitis B surface antigen carriers. Ann Intern Med 118:191-194
24. Lindh M, Horal P, Dhillon AP, Norkrans G (2000) Hepatitis B virus DNA levels, precore mutations, genotypes and histological activity in chronic hepatitis B. J Viral Hepat 7:258-267
25. Loriot MA, Marcellin P, Walker F, Boyer N, Degott C, Randrianatoavina I, Benhamou JP, Erlinger S (1997) Persistence of hepatitis B virus DNA in serum and liver from patients with chronic hepatitis B after loss of HBsAg. J Hepatol 27:251-258
26. Gandhi MJ, Yang GG, McMahon B, Vyas G (2000) Hepatitis B virions isolated with antibodies to the pre-S1 domain reveal occult viremia in surface antigen negative/antibody-positive carriers by polymerase chain reaction. Transfusion 40:910-916
27. Mukaide M, Tanaka Y, Katayose S, Tano H, Murata M, Hikata M, Fujise K, Sakugawa H, Suzuki K, Zaunders J, Nagasawa Y, Toda G, Mizokami M (2003) Development of real-time detection direct test for hepatitis B virus and comparison with two commercial tests using the WHO international standard. J Gastroenterol Hepatol 18:1264-1271
28. Huo TI, Wu JC, Lee PC, Chau GY, Lui WY, Tsay SH, Ting LT, Chang FY, Lee SD (1998) Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis. Hepatology 28:231-236
29. Chaudhuri V, Tayal R, Nayak B, Acharya SK, Panda SK (2004) Occult hepatitis B virus infection in chronic liver disease: Full-length genome and analysis of mutant surface promoter. Gastroenterology 127:1356-1371
30. Huy TT, Ushijima H, Win KM, Luengrojanakul P, Shrestha PK, Zhong ZH, Smirnov AV, Taltavull TC, Sata T, Abe K (2003) High prevalence of hepatitis B virus pre-s mutant in countries where it is endemic and its relationship with genotype and chronicity. J Clin Microbiol 41:5449-5455